202 related articles for article (PubMed ID: 34311770)
1. Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events.
Ajeganova S; Andersson MLE; Frostegård J; Hafström I
Arthritis Res Ther; 2021 Jul; 23(1):201. PubMed ID: 34311770
[TBL] [Abstract][Full Text] [Related]
2. Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men.
Gigante B; Leander K; Vikström M; Baldassarre D; Veglia F; Strawbridge RJ; McLeod O; Gertow K; Sennblad B; Shah S; Zabaneh D; Humphries SE; Kauhanen J; Rauramaa R; Smit AJ; Mannarino E; Giral P; Tremoli E; Hamsten A; Frostegård J; de Faire U;
Atherosclerosis; 2014 Oct; 236(2):394-9. PubMed ID: 25150937
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
[TBL] [Abstract][Full Text] [Related]
4. Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study.
Ajeganova S; de Faire U; Jogestrand T; Frostegård J; Hafström I
J Rheumatol; 2012 Jun; 39(6):1146-54. PubMed ID: 22589258
[TBL] [Abstract][Full Text] [Related]
5. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis.
Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP;
Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.
Innala L; Möller B; Ljung L; Magnusson S; Smedby T; Södergren A; Öhman ML; Rantapää-Dahlqvist S; Wållberg-Jonsson S
Arthritis Res Ther; 2011 Aug; 13(4):R131. PubMed ID: 21843325
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study.
Ajeganova S; Ehrnfelt C; Alizadeh R; Rohani M; Jogestrand T; Hafström I; Frostegård J
Rheumatology (Oxford); 2011 Oct; 50(10):1785-93. PubMed ID: 21743088
[TBL] [Abstract][Full Text] [Related]
8. Effect of biological therapy on levels of atheroprotective antibodies against phosphorylcholine and apolipoproteins in rheumatoid arthritis - a one year study.
Ajeganova S; Fiskesund R; de Faire U; Hafström I; Frostegård J
Clin Exp Rheumatol; 2011; 29(6):942-50. PubMed ID: 22153361
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study.
Elkan AC; Håkansson N; Frostegård J; Cederholm T; Hafström I
Arthritis Res Ther; 2009; 11(2):R37. PubMed ID: 19284557
[TBL] [Abstract][Full Text] [Related]
10. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius ML; Wikström M; Dahlbom I; Grönlund H; Frostegård J
J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160
[TBL] [Abstract][Full Text] [Related]
11. Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
Arts EE; Fransen J; Den Broeder AA; van Riel PLCM; Popa CD
Ann Rheum Dis; 2017 Oct; 76(10):1693-1699. PubMed ID: 28606965
[TBL] [Abstract][Full Text] [Related]
12. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
[TBL] [Abstract][Full Text] [Related]
13. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men.
Sjöberg BG; Su J; Dahlbom I; Grönlund H; Wikström M; Hedblad B; Berglund G; de Faire U; Frostegård J
Atherosclerosis; 2009 Apr; 203(2):528-32. PubMed ID: 18809177
[TBL] [Abstract][Full Text] [Related]
14. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
[TBL] [Abstract][Full Text] [Related]
16. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
[TBL] [Abstract][Full Text] [Related]
17. Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.
Gingnell M; Dahlbom I; Lindholm A; Hudecova M; Arnadottir R; Hansson T; Sundstrom-Poromaa I
Gynecol Endocrinol; 2011 Jul; 27(7):486-90. PubMed ID: 20645890
[TBL] [Abstract][Full Text] [Related]
18. IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome.
Knudsen EC; Seljeflot I; Aksnes TA; Eritsland J; Arnesen H; Andersen GØ
PLoS One; 2019; 14(4):e0215640. PubMed ID: 31002684
[TBL] [Abstract][Full Text] [Related]
19. IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes.
Caidahl K; Hartford M; Karlsson T; Herlitz J; Pettersson K; de Faire U; Frostegård J
Int J Cardiol; 2013 Jul; 167(2):464-9. PubMed ID: 22305633
[TBL] [Abstract][Full Text] [Related]
20. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Frostegård J
Nephrol Dial Transplant; 2009 Nov; 24(11):3454-60. PubMed ID: 19549697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
